Free Trial

Blueprint Medicines (BPMC) SEC Filings & 10K Form

Blueprint Medicines logo
$90.14 +1.21 (+1.36%)
(As of 12/20/2024 05:31 PM ET)

Recent Blueprint Medicines SEC Filings

DateFilerForm TypeView
12/20/2024
3:15 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:15 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
4:17 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:31 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
6:51 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
3:52 PM
Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
4:33 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
5:52 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:40 PM
Blueprint Medicines (Subject)
Haviland Kate (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:51 PM
Blueprint Medicines (Subject)
Rossi Christina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:47 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:23 PM
Blueprint Medicines (Subject)
COATS LONNEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
12:44 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144/A
11/07/2024
4:24 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
3:27 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:07 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:09 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:06 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:22 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
3:27 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
4:06 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
3:50 PM
Blueprint Medicines (Subject)
Lee Philina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:48 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
6:29 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
6:07 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:08 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:54 PM
Blueprint Medicines (Subject)
Durso-Bumpus Debra (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/21/2024
3:36 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2024
4:32 PM
Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:32 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:34 PM
Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:34 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:35 PM
Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:36 PM
Blueprint Medicines (Issuer)
Tsai John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:37 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:38 PM
Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:41 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:11 PM
Blueprint Medicines (Subject)
Carter Percy H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
3:40 PM
Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Hewes L. Becker (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
3:38 PM
Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
7:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

05/06/2024
4:19 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:26 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:43 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
6:09 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:09 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:24 PM
Blueprint Medicines (Filer)
Form DEF 14A
04/25/2024
4:25 PM
Blueprint Medicines (Filer)
Form ARS
04/25/2024
7:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
11:58 AM
Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
03/28/2024
4:57 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
8:11 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:50 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:22 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:46 PM
Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:47 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:17 PM
Blueprint Medicines (Subject)
Lee Philina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
5:24 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:26 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:27 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:28 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:29 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:15 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:18 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:19 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:20 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:21 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:23 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:22 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:15 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:16 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:17 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:18 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:19 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:21 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:41 AM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:19 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
2:06 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:03 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
7:20 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:40 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/15/2024
4:26 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
6:05 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
5:54 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:35 AM
Blueprint Medicines (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/29/2024
5:13 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
Form SC 13G/A
01/10/2024
9:16 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/08/2024
7:03 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Buy this coin BEFORE Inauguration Day … (Ad)

Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.

12/26/2023
3:24 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BPMC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners